Paul J. Schmitt
Paul Schmitt has served as Managing Director of Novitas Capital in Wayne, Pennsylvania since 1999. As Managing Director, he oversees Novitas Capital’s interests in early stage life sciences companies. In May of 2009, Mr. Schmitt assumed an additional role of Acting CEO of Amorcyte, a Novitas portfolio company, developing cell therapies for Cardiovascular Disease and AMI.
In October 2011, Amorcyte was sold to Neostem (AMEX:NBS) for total proceeds of $18Million plus 30% of all revenues resulting from any strategic partnerships or licensing agreements.